Skip to main content

Nathan Witman Ph.D.

  • Postdoctoral Associate, M. Shlomchik Lab

    Education & Training

  • Postdoctoral Associate, Department of Immunology, University of Pittsburgh [2026-present]
  • PhD in Microbiology and Immunology with an emphasis in Basic and Translational Science [2026], Medical College of Wisconsin - Milwaukee
  • MS in Biology with an emphasis on Microbiology [2021], University of Wisconsin - Oshkosh
  • BS in Biology, Chemistry, and Spanish with a minor in Microbiology [2018] Magna Cum Laude, University of Wisconsin - Oshkosh
Representative Publications
Witman N.*, Yu M.*, Zhang Y., Gai K., Chen Y., Zhou L., Nguyen C., Zhu W., Zheng Y., Jobe S.M., Graham M.B., Cui W., Wang D., Wen R. Atypical memory B-cell clonal expansion and inflammatory programs associate with platelet-activating antibody development in COVID-19. JCI Insight. Published February 26, 2026. doi:10.1172/jci.insight.201033. PMID:41746733
 
Zhu, W.*, Zheng, Y.*, Yu, M.*, Witman, N., Zhou, L., Wei, J., Zhang, Y., Topchyan, P., Nguyen, C., Janecke, R., Padmanabhan, A., Baumann Kreuziger, L., White, G. C., Hari, P., Gu, T., Fields, A. T., Kornblith, L., Aster, R. H., Zhu, J., . . . Wen, R. Prothrombotic antibodies targeting the spike protein's receptor-binding domain in severe COVID-19. Blood. 2025 Feb 6;145(6):635-647. doi: 10.1182/blood.2024025010. PMID: 39576992; PMCID: PMC11811936.
Zur Tulod, J., Witman, ND., Grond, K., Duddleston KN., Kurtz, CC. Treatment with gut-specific nonsteroidal anti-inflammatory drug attenuates metabolic inflammation but not body mass in fattening ground squirrels. Am J Physiol Regul Integr Comp Physiol. 2023 Nov 1;325(5):R456-R464. doi:10.1152/ajpregu.00078.2023. Epub 2023 Aug 21. PMID: 37602382.
 
For a current and full list of my work please see My Bibliography at https://www.ncbi.nlm.nih.gov/myncbi/nathan.witman.2/bibliography/public/